Mychal James Bradley Gibbens
Examiner (ID: 6474)
Most Active Art Unit | 2662 |
Art Unit(s) | 2662 |
Total Applications | 2 |
Issued Applications | 2 |
Pending Applications | 0 |
Abandoned Applications | 0 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 13551831
[patent_doc_number] => 20180327463
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-15
[patent_title] => Peptides
[patent_app_type] => utility
[patent_app_number] => 15/903379
[patent_app_country] => US
[patent_app_date] => 2018-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12380
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15903379
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/903379 | Peptides | Feb 22, 2018 | Issued |
Array
(
[id] => 15342685
[patent_doc_number] => 20200009234
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-09
[patent_title] => METHODS AND USES OF ALPHA 1-ANTITRYPSIN FOR EARLY INTERVENTION IN PULMONARY DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/487214
[patent_app_country] => US
[patent_app_date] => 2018-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9673
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16487214
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/487214 | Methods and uses of alpha 1-antitrypsin for early intervention in pulmonary diseases | Feb 20, 2018 | Issued |
Array
(
[id] => 15145067
[patent_doc_number] => 20190351011
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-21
[patent_title] => PHARMACEUTICAL COMPOSITION FOR ANTI-ANGIOGENESIS CONTAINING CYCLIC PENTADEPSIPEPTIDE AS AN EFFECTIVE INGREDIENT
[patent_app_type] => utility
[patent_app_number] => 16/320502
[patent_app_country] => US
[patent_app_date] => 2018-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6320
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16320502
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/320502 | Pharmaceutical composition for anti-angiogenesis containing cyclic pentadepsipeptide as an effective ingredient | Feb 5, 2018 | Issued |
Array
(
[id] => 14599523
[patent_doc_number] => 10352951
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-16
[patent_title] => Sensors for assaying coagulation in fluid samples
[patent_app_type] => utility
[patent_app_number] => 15/879714
[patent_app_country] => US
[patent_app_date] => 2018-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 49
[patent_no_of_words] => 26279
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15879714
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/879714 | Sensors for assaying coagulation in fluid samples | Jan 24, 2018 | Issued |
Array
(
[id] => 12790681
[patent_doc_number] => 20180155396
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-07
[patent_title] => STRUCTURE-BASED PEPTIDE INHIBITORS OF P53 AGGREGATION AS A NEW APPROACH TO CANCER THERAPEUTICS
[patent_app_type] => utility
[patent_app_number] => 15/877134
[patent_app_country] => US
[patent_app_date] => 2018-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19023
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15877134
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/877134 | Structure-based peptide inhibitors of P53 aggregation as a new approach to cancer therapeutics | Jan 21, 2018 | Issued |
Array
(
[id] => 13918451
[patent_doc_number] => 10203337
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-02-12
[patent_title] => Kisspeptin-54 detection by tandem mass spectrometry
[patent_app_type] => utility
[patent_app_number] => 15/875850
[patent_app_country] => US
[patent_app_date] => 2018-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 20
[patent_no_of_words] => 11431
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15875850
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/875850 | Kisspeptin-54 detection by tandem mass spectrometry | Jan 18, 2018 | Issued |
Array
(
[id] => 15083545
[patent_doc_number] => 20190336583
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-07
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING IRON OVERLOAD
[patent_app_type] => utility
[patent_app_number] => 16/478998
[patent_app_country] => US
[patent_app_date] => 2018-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12840
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -118
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16478998
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/478998 | COMPOSITIONS AND METHODS FOR TREATING IRON OVERLOAD | Jan 17, 2018 | Abandoned |
Array
(
[id] => 12769930
[patent_doc_number] => 20180148478
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-31
[patent_title] => Melanocortin Receptor-Specific Peptide with C-Terminal Naphthylalanine
[patent_app_type] => utility
[patent_app_number] => 15/873180
[patent_app_country] => US
[patent_app_date] => 2018-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24714
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15873180
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/873180 | Melanocortin receptor-specific peptide with C-terminal naphthylalanine | Jan 16, 2018 | Issued |
Array
(
[id] => 13586541
[patent_doc_number] => 20180344819
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-06
[patent_title] => COMPOSITIONS AND METHODS FOR COUNTERACTING FACTOR XA INHIBITION
[patent_app_type] => utility
[patent_app_number] => 15/873416
[patent_app_country] => US
[patent_app_date] => 2018-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12805
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15873416
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/873416 | Compositions and methods for counteracting Factor Xa inhibition | Jan 16, 2018 | Issued |
Array
(
[id] => 13386365
[patent_doc_number] => 20180244724
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-30
[patent_title] => POLYPEPTIDE COMPOUND AND PREPARATION METHOD AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/871218
[patent_app_country] => US
[patent_app_date] => 2018-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8758
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15871218
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/871218 | POLYPEPTIDE COMPOUND AND PREPARATION METHOD AND USE THEREOF | Jan 14, 2018 | Abandoned |
Array
(
[id] => 13383677
[patent_doc_number] => 20180243380
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-30
[patent_title] => RAPID ACTION INSULIN FORMULATIONS AND PHARMACEUTICAL DELIVERY SYSTEMS
[patent_app_type] => utility
[patent_app_number] => 15/869350
[patent_app_country] => US
[patent_app_date] => 2018-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17714
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15869350
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/869350 | Rapid action insulin formulations and pharmaceutical delivery systems | Jan 11, 2018 | Issued |
Array
(
[id] => 15119643
[patent_doc_number] => 20190346454
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-14
[patent_title] => Reagents and Methods for Analysis of Proteins and Metabolites Targeted by Covalent Probes
[patent_app_type] => utility
[patent_app_number] => 16/461486
[patent_app_country] => US
[patent_app_date] => 2017-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18500
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16461486
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/461486 | Reagents and methods for analysis of proteins and metabolites targeted by covalent probes | Nov 27, 2017 | Issued |
Array
(
[id] => 16635278
[patent_doc_number] => 10913773
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-09
[patent_title] => Bicyclic peptidyl inhibitor of tumor necrosis factor-alpha
[patent_app_type] => utility
[patent_app_number] => 16/462914
[patent_app_country] => US
[patent_app_date] => 2017-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 17
[patent_no_of_words] => 26625
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16462914
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/462914 | Bicyclic peptidyl inhibitor of tumor necrosis factor-alpha | Nov 21, 2017 | Issued |
Array
(
[id] => 17649680
[patent_doc_number] => 11352394
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-07
[patent_title] => Cyclic cell penetrating peptides comprising beta-hairpin motifs and methods of making and using thereof
[patent_app_type] => utility
[patent_app_number] => 16/462920
[patent_app_country] => US
[patent_app_date] => 2017-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 18
[patent_no_of_words] => 24662
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16462920
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/462920 | Cyclic cell penetrating peptides comprising beta-hairpin motifs and methods of making and using thereof | Nov 21, 2017 | Issued |
Array
(
[id] => 12260637
[patent_doc_number] => 20180079833
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-22
[patent_title] => 'BONDING TISSUES AND CROSS-LINKING PROTEINS WITH NAPHTHALIMIDE COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 15/815855
[patent_app_country] => US
[patent_app_date] => 2017-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 14183
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15815855
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/815855 | Bonding tissues and cross-linking proteins with naphthalimide compounds | Nov 16, 2017 | Issued |
Array
(
[id] => 16663948
[patent_doc_number] => 10933171
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-02
[patent_title] => Collagen sol for submucosal local injection
[patent_app_type] => utility
[patent_app_number] => 16/461552
[patent_app_country] => US
[patent_app_date] => 2017-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 6970
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16461552
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/461552 | Collagen sol for submucosal local injection | Nov 15, 2017 | Issued |
Array
(
[id] => 12231920
[patent_doc_number] => 20180064783
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-08
[patent_title] => 'PRODUCTS AND METHODS USING SOY PEPTIDES TO LOWER TOTAL AND LDL CHOLESTEROL LEVELS'
[patent_app_type] => utility
[patent_app_number] => 15/811666
[patent_app_country] => US
[patent_app_date] => 2017-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 20865
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15811666
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/811666 | Products and methods using soy peptides to lower total and LDL cholesterol levels | Nov 12, 2017 | Issued |
Array
(
[id] => 12219179
[patent_doc_number] => 20180057536
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-01
[patent_title] => 'SELECTIVE DELIVERY MOLECULES AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 15/806246
[patent_app_country] => US
[patent_app_date] => 2017-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 55714
[patent_no_of_claims] => 238
[patent_no_of_ind_claims] => 38
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15806246
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/806246 | Selective delivery molecules and methods of use | Nov 6, 2017 | Issued |
Array
(
[id] => 12219179
[patent_doc_number] => 20180057536
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-01
[patent_title] => 'SELECTIVE DELIVERY MOLECULES AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 15/806246
[patent_app_country] => US
[patent_app_date] => 2017-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 55714
[patent_no_of_claims] => 238
[patent_no_of_ind_claims] => 38
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15806246
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/806246 | Selective delivery molecules and methods of use | Nov 6, 2017 | Issued |
Array
(
[id] => 12219179
[patent_doc_number] => 20180057536
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-01
[patent_title] => 'SELECTIVE DELIVERY MOLECULES AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 15/806246
[patent_app_country] => US
[patent_app_date] => 2017-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 55714
[patent_no_of_claims] => 238
[patent_no_of_ind_claims] => 38
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15806246
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/806246 | Selective delivery molecules and methods of use | Nov 6, 2017 | Issued |